Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu & SeungHwan Lee. (2021) Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study. Drug Design, Development and Therapy 15, pages 651-658.
Read now
Read now
Carmen Almansa, Christopher S Frampton, José Miguel Vela, Steve Whitelock & Carlos R Plata-Salamán. (2019) Co-crystals as a new approach to multimodal analgesia and the treatment of pain. Journal of Pain Research 12, pages 2679-2689.
Read now
Read now
Zan Liu, Weiwei Wang, Hao Chen, Jianping Liu & Wenli Zhang. (2016) Novel application method of talcum powder to prevent sticking tendency and modify release of esomeprazole magnesium enteric-coated pellets. Pharmaceutical Development and Technology 21:4, pages 405-414.
Read now
Read now
Felipe L Lopez, Terry B Ernest, Catherine Tuleu & Mine Orlu Gul. (2015) Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opinion on Drug Delivery 12:11, pages 1727-1740.
Read now
Read now
Articles from other publishers (61)
Sun Ho Kim, Jung Han Kook, Dong-Wan Seo & Myung Joo Kang. (2023) The Effect of Compression Pressure on the First Layer Surface Roughness and Delamination of Metformin and Evogliptin Bilayer and Trilayer Tablets. Pharmaceuticals 16:11, pages 1523.
Crossref
Crossref
Fernando Silva, Gustavo Costa, Francisco Veiga, Catarina Cardoso & Ana Cláudia Paiva-Santos. (2023) Parenteral Ready-to-Use Fixed-Dose Combinations Including NSAIDs with Paracetamol or Metamizole for Multimodal Analgesia—Approved Products and Challenges. Pharmaceuticals 16:8, pages 1084.
Crossref
Crossref
Rosmery Merma Leon, Michele Georges Issa, Marcelo Dutra Duque, Josiane Souza Pereira Daniel & Humberto Gomes Ferraz. (2023) Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets. Pharmaceutics 15:6, pages 1735.
Crossref
Crossref
Céline van Haaren, Marieke De Bock & Sergei G. Kazarian. (2023) Advances in ATR-FTIR Spectroscopic Imaging for the Analysis of Tablet Dissolution and Drug Release. Molecules 28:12, pages 4705.
Crossref
Crossref
Amir Naghizadeh, Mohammad Ali Salehi & Leila Mivehi. (2023) Response surface methodology study of extended-time metformin/Glibenclamide drug delivery system from polycaprolactone/Polyethylene glycol electrospun nanofibers. Journal of Polymer Research 30:6.
Crossref
Crossref
J. Simão, S.A. Chaudhary & A.J. Ribeiro. (2023) Implementation of Quality by Design (QbD) for development of bilayer tablets. European Journal of Pharmaceutical Sciences 184, pages 106412.
Crossref
Crossref
Muthukumar Subramanian, Chellam Sankar, Gayathri Rajaram & Vinesha Ravi. 2023. Dosage Forms - Innovation and Future Perspectives. Dosage Forms - Innovation and Future Perspectives.
Sunil Chaudhry. (2023) Fixed dose combinations in India- what a way to go!. Indian Journal of Pharmacy and Pharmacology 10:1, pages 45-49.
Crossref
Crossref
Diren Sarisaltik-Yasin, Abdullah Uslu, Emre Uyar, Meral Erdinc & Zeynep Safak Teksin. (2022) QbD Application for a Fixed-Dose Combination with Biowaiver Potential: Evaluations of In Vitro and In Vivo Applications. Journal of Pharmaceutical Innovation 18:1, pages 164-181.
Crossref
Crossref
Abdulmajeed A. Althobaiti, Eman A. Ashour, Ahmed Almotairy, Mashan Almutairi, Mohammed AlYahya & Michael A. Repka. (2023) Development and characterization of different dosage forms of nifedipine/indomethacin fixed-dose combinations. Journal of Drug Delivery Science and Technology 80, pages 104117.
Crossref
Crossref
Raquel Fernández-García, David Walsh, Peter O'Connell, Karla Slowing, Rafaela Raposo, M. Paloma Ballesteros, Aurora Jiménez-Cebrián, Manuel J. Chamorro-Sancho, Francisco Bolás-Fernández, Anne Marie Healy & Dolores R. Serrano. (2023) Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses. European Journal of Pharmaceutics and Biopharmaceutics 183, pages 74-91.
Crossref
Crossref
Bo-Ying Ren, Xia-Lin Dai, Fang Zhang, Xiangtian Long, Yong-Liang Huang, Jia-Mei Chen & Tong-Bu Lu. (2022) “Drug–Coformer–Drug” Multicomponent Crystals to Simultaneously Improve the Solubility of Two Insoluble Combined Drugs by Introduction of a Soluble Coformer. Crystal Growth & Design 22:10, pages 5785-5790.
Crossref
Crossref
Dong Han Won, Heejun Park, Jeong-Woong Seo, Sun Woo Jang, Eun-Sol Ha & Min-Soo Kim. (2022) Active coating of immediate-release evogliptin tartrate to prepare fixed dose combination tablet with sustained-release metformin HCl. International Journal of Pharmaceutics 623, pages 121927.
Crossref
Crossref
Kumaravelrajan R, Thirumaran M, Sangavi T & Suba V. (2022) PREPARATION AND EVALUATION OF ACTIVE FILM COATING TABLET OF TENELIGLIPTIN HYDROBROMIDE HYDRATE WITH METFORMIN HYDROCHLORIDE FIXED DOSE COMBINATION. INDIAN DRUGS 58:12, pages 22-31.
Crossref
Crossref
Hyun Chul Kim, Deok Yong Yoon, SeungHwan Lee, In-Jin Jang, Jang Hee Hong & JaeWoo Kim. (2022) Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination. Translational and Clinical Pharmacology 30:2, pages 112.
Crossref
Crossref
Inseung Jeon, Seol Ju Moon, Sang‐In Park, Yewon Choi, Jina Jung, Kyung‐Sang Yu & Jae‐Yong Chung. (2021) Pharmacokinetics of a Fixed‐Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components. Clinical Pharmacology in Drug Development 11:1, pages 91-99.
Crossref
Crossref
Anitha Sriram, Suma Tangirala, Srividya Atmakuri, Sajid Hoque, Sheela Modani, Saurabh Srivastava, Srushti Mahajan, Indrani Maji, Rahul Kumar, Dharmendra Khatri, Jitender Madan & Pankaj Kumar Singh. (2021) Budding Multi-matrix Technology—a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 22:8.
Crossref
Crossref
Hongmei Li, Yingying Yao & Huizhi Fu. (2021) Novel pediatric suspension of nanoparticulate zafirlukast for the treatment of asthma: Assessment and evaluation in animal model. Micro & Nano Letters 16:10, pages 485-491.
Crossref
Crossref
Dong-Wook Kim & Kwon Yeon Weon. (2021) Pharmaceutical application and development of fixed-dose combination: dosage form review. Journal of Pharmaceutical Investigation 51:5, pages 555-570.
Crossref
Crossref
Sanika KOLE, Ashwin KUCHEKAR & Dnyanesh LİMAYE. (2021) Advancements in Formulation Approaches to Pediatric Oral Drug Delivery systems. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Daniel Zakowiecki, Maja Frankiewicz, Tobias Hess, Krzysztof Cal, Maciej Gajda, Justyna Dabrowska, Bartlomiej Kubiak, Jadwiga Paszkowska, Marcela Wiater, Dagmara Hoc, Grzegorz Garbacz & Dorota Haznar-Garbacz. (2021) Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets. Pharmaceutics 13:6, pages 805.
Crossref
Crossref
Amit Kaushal, Sandeep Arora, Neelam Sharma & Sukhbir Singh. (2021) Development of Bilayer Tablet Containing Saxagliptin Immediate Release and Metformin Sustained Release Using Quality by Design Approach. Current Drug Therapy 16:2, pages 184-203.
Crossref
Crossref
Lixiang Zhao, Mine Orlu & Gareth R. Williams. (2021) Electrospun fixed dose combination fibers for the treatment of cardiovascular disease. International Journal of Pharmaceutics 599, pages 120426.
Crossref
Crossref
Kwadwo Amanor Mfoafo, Masoud Omidian, Charise Dallazem Bertol, Yadollah Omidi & Hossein Omidian. (2021) Neonatal and pediatric oral drug delivery: Hopes and hurdles. International Journal of Pharmaceutics 597, pages 120296.
Crossref
Crossref
Jamshed Haneef, Shakir Ali & Renu Chadha. (2021) Emerging Multi-Drug Eutectics: Opportunities and Challenges. AAPS PharmSciTech 22:2.
Crossref
Crossref
Ki Young Huh, Eunwoo Kim, Heechan Lee, Inseung Jeon, Hearan Suh, Jongsun Lee, Yunhee Lee, Kyung‐Sang Yu & SeungHwan Lee. (2020) Comparison of the Pharmacokinetics of a Fixed‐Dose Combination of Rosuvastatin/Metformin Sustained‐Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects. Clinical Pharmacology in Drug Development 10:2, pages 207-213.
Crossref
Crossref
Jesse Yu, Danni Yu, Sarah Lane, Lisa McConnachie & Rodney J.Y. Ho. (2020) Controlled Solvent Removal from Antiviral Drugs and Excipients in Solution Enables the Formation of Novel Combination Multi-Drug-Motifs in Pharmaceutical Powders Composed of Lopinavir, Ritonavir and Tenofovir. Journal of Pharmaceutical Sciences 109:11, pages 3480-3489.
Crossref
Crossref
Mira El Sayed, Amjad Alhalaweh & Christel A. S. Bergström. (2020) Insights into Dissolution and Solution Chemistry of Multidrug Formulations of Antihypertensive Drugs. Molecular Pharmaceutics 17:10, pages 4018-4028.
Crossref
Crossref
Raquel Fernández-García, María Prada, Francisco Bolás-Fernández, M. Paloma Ballesteros & Dolores R. Serrano. (2020) Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing. Pharmaceutical Research 37:7.
Crossref
Crossref
Reiji Yokoyama, Go Kimura, Jörg Huwyler, Ken-ichi Hosoya & Maxim Puchkov. (2020) Impact of Insoluble Separation Layer Mechanical Properties on Disintegration and Dissolution Kinetics of Multilayer Tablets. Pharmaceutics 12:6, pages 495.
Crossref
Crossref
Chunyang Guo, Qi Zhang, Bingqing Zhu, Zaiyong Zhang, Xiaoyu Ma, Wenjuan Dai, Xiaoyi Gong, Guobin Ren & Xuefeng Mei. (2020) Drug–Drug Cocrystals Provide Significant Improvements of Drug Properties in Treatment with Progesterone. Crystal Growth & Design 20:5, pages 3053-3063.
Crossref
Crossref
Annelies Smeets, Ida Lo Re, Christian Clasen & Guy Van den Mooter. (2020) Fixed dose combinations for cardiovascular treatment via coaxial electrospraying: Coated amorphous solid dispersion particles. International Journal of Pharmaceutics 577, pages 118949.
Crossref
Crossref
Shao-Yu Chang & Changquan Calvin Sun. (2020) Interfacial bonding in formulated bilayer tablets. European Journal of Pharmaceutics and Biopharmaceutics 147, pages 69-75.
Crossref
Crossref
Enrica Menditto, Valentina Orlando, Giuseppe De Rosa, Paola Minghetti, Umberto Musazzi, Caitriona Cahir, Marta Kurczewska-Michalak, Przemysław Kardas, Elísio Costa, José Sousa Lobo & Isabel Almeida. (2020) Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence. Pharmaceutics 12:1, pages 44.
Crossref
Crossref
Mathew John. (2020) More vigilance on generic drugs are necessary. Indian Journal of Endocrinology and Metabolism 24:2, pages 215.
Crossref
Crossref
Suet Li Chew, Laura Modica de Mohac & Bahijja Tolulope Raimi-Abraham. (2019) 3D-Printed Solid Dispersion Drug Products. Pharmaceutics 11:12, pages 672.
Crossref
Crossref
Tomasz Blicharski, Katarzyna Swiader, Anna Serefko, Sylwia Kulczycka-Mamona, Michal Kolodziejczyk & Aleksandra Szopa. (2019) Challenges in technology of bilayer and multi-layer tablets: a mini-review. Current Issues in Pharmacy and Medical Sciences 32:4, pages 229-235.
Crossref
Crossref
Shao-Yu Chang & Changquan Calvin Sun. (2019) Effect of particle size on interfacial bonding strength of bilayer tablets. Powder Technology 356, pages 97-101.
Crossref
Crossref
Brusač, Jeličić, Amidžić Klarić, Nigović, Turk, Klarić & Mornar. (2019) Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods. Molecules 24:19, pages 3469.
Crossref
Crossref
Shao-Yu Chang & Changquan Calvin Sun. (2019) Insights into the effect of compaction pressure and material properties on interfacial bonding strength of bilayer tablets. Powder Technology 354, pages 867-876.
Crossref
Crossref
Bart Hens, Maura Corsetti, Marival Bermejo, Raimar Löbenberg, Pablo M. González, Amitava Mitra, Divyakant Desai, Dakshina Murthy Chilukuri & Alexis Aceituno. (2019) “Development of Fixed Dose Combination Products” Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy. The AAPS Journal 21:4.
Crossref
Crossref
T. Shams, F. Brako, S. Huo, A. H. Harker, U. Edirisinghe & M. Edirisinghe. (2019) The influence of drug solubility and sampling frequency on metformin and glibenclamide release from double-layered particles: experimental analysis and mathematical modelling. Journal of The Royal Society Interface 16:155, pages 20190237.
Crossref
Crossref
Giovanny Acosta-Vélez, Chase Linsley, Timothy Zhu, Willie Wu & Benjamin Wu. (2018) Photocurable Bioinks for the 3D Pharming of Combination Therapies. Polymers 10:12, pages 1372.
Crossref
Crossref
Haitham Bukhary, Gareth R. Williams & Mine Orlu. (2018) Electrospun fixed dose formulations of amlodipine besylate and valsartan. International Journal of Pharmaceutics 549:1-2, pages 446-455.
Crossref
Crossref
Muzna Sadia, Abdullah Isreb, Ibrahim Abbadi, Mohammad Isreb, David Aziz, Amjad Selo, Peter Timmins & Mohamed A. Alhnan. (2018) From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. European Journal of Pharmaceutical Sciences 123, pages 484-494.
Crossref
Crossref
Jana Šalandová, Aleš Franc, Jiří Hofmann, Aleksandra Dumicic, Lenka Kukačková, Tereza Červená, Josef Beránek, Jan Srbek, Andrej Repický, Beata Vladovičová & David Vetchý. (2018) The effect of the composition of a fixed dose combination on bioequivalence results. International Journal of Pharmaceutics 546:1-2, pages 235-246.
Crossref
Crossref
José López-Cedrún, Sebastián Videla, Miguel Burgueño, Inma Juárez, Samir Aboul-Hosn, Rafael Martín-Granizo, Joan Grau, Miguel Puche, José-Luis Gil-Diez, José-Antonio Hueto, Anna Vaqué, Mariano Sust, Carlos Plata-Salamán & Antoni Monner. (2018) Co-crystal of Tramadol–Celecoxib in Patients with Moderate to Severe Acute Post-surgical Oral Pain: A Dose-Finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre, Phase II Trial. Drugs in R&D 18:2, pages 137-148.
Crossref
Crossref
Manjeet B. Pimparade, Anh Vo, Abhijeet S. Maurya, Jungeun Bae, Joseph T. Morott, Xin Feng, Dong Wuk Kim, Vijay I. Kulkarni, Roshan Tiwari, K. Vanaja, Reena Murthy, H.N. Shivakumar, D. Neupane, S.R. Mishra, S.N. Murthy & Michael A. Repka. (2017) Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology. European Journal of Pharmaceutics and Biopharmaceutics 119, pages 81-90.
Crossref
Crossref
Carmen Almansa, Ramon Mercè, Nicolas Tesson, Joan Farran, Jaume Tomàs & Carlos R. Plata-Salamán. (2017)
Co-crystal of Tramadol Hydrochloride–Celecoxib (
ctc
): A Novel API–API Co-crystal for the Treatment of Pain
. Crystal Growth & Design 17:4, pages 1884-1892.
Crossref
Crossref
J.M. Rowe & F. Nikfar. 2017. Predictive Modeling of Pharmaceutical Unit Operations. Predictive Modeling of Pharmaceutical Unit Operations
229
251
.
W. Brett Caldwell & Aditya M. Kaushal. 2017. Multiparticulate Drug Delivery. Multiparticulate Drug Delivery
155
168
.
Cheol Moon & Euichaul Oh. (2016) Rationale and strategies for formulation development of oral fixed dose combination drug products. Journal of Pharmaceutical Investigation 46:7, pages 615-631.
Crossref
Crossref
Sara M. Hanning, Felipe L. Lopez, Ian C.K. Wong, Terry B. Ernest, Catherine Tuleu & Mine Orlu Gul. (2016) Patient centric formulations for paediatrics and geriatrics: Similarities and differences. International Journal of Pharmaceutics 512:2, pages 355-359.
Crossref
Crossref
Felipe L. Lopez, Alexandra Bowles, Mine Orlu Gul, David Clapham, Terry B. Ernest & Catherine Tuleu. (2016) Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. European Journal of Pharmaceutical Sciences 92, pages 156-162.
Crossref
Crossref
David P. Elder, Martin Kuentz & René Holm. (2016) Antibiotic Resistance: The Need For a Global Strategy. Journal of Pharmaceutical Sciences 105:8, pages 2278-2287.
Crossref
Crossref
Moolchand Kurmi, Bhoopendra Singh Kushwah, Archana Sahu, Mallikarjun Narayanam & Saranjit Singh. (2016) Stability behaviour of antiretroviral drugs and their combinations. 2: Characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR spectrometry. Journal of Pharmaceutical and Biomedical Analysis 125, pages 245-259.
Crossref
Crossref
Ping Liu, Zhiyong Hu, Byron G. DuBois, Christopher R. Moyes, David N. Hunter, Cheng Zhu, Nam Fung Kar, Yuping Zhu, Joie Garfunkle, Ling Kang, Gary Chicchi, Anka Ehrhardt, Andrea Woods, Toru Seo, Morgan Woods, Margaret van Heek, Karen H. Dingley, Jianmei Pang, Gino M. Salituro, Joyce Powell, Jenna L. Terebetski, Viktor Hornak, Louis-Charles Campeau, Joe Lamberson, Fez Ujjainwalla, Michael Miller, Andrew Stamford, Harold B. Wood, Timothy Kowalski, Ravi P. Nargund & Scott D. Edmondson. (2015) Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. ACS Medicinal Chemistry Letters 6:8, pages 936-941.
Crossref
Crossref
Jonathan G. Shackman & Brent L. Kleintop. (2014) Peak purity assessment in a triple-active fixed-dose combination drug product related substances method using a commercial two-dimensional liquid chromatography system. Journal of Separation Science 37:19, pages 2688-2695.
Crossref
Crossref
Admassu Abebe, Ilgaz Akseli, Omar Sprockel, Niranjan Kottala & Alberto M. Cuitiño. (2014) Review of bilayer tablet technology. International Journal of Pharmaceutics 461:1-2, pages 549-558.
Crossref
Crossref
Masahiro Niwa, Yasuhiro Hiraishi, Norio Iwasaki & Katsuhide Terada. (2013) Quantitative analysis of the layer separation risk in bilayer tablets using terahertz pulsed imaging. International Journal of Pharmaceutics 452:1-2, pages 249-256.
Crossref
Crossref
Shinzo HiroiKenkichi SugiuraKumi MatsunoMasashi HirayamaKenji KuriyamaKohei KakuKoji Kawakami. (2013) A Multicenter, Phase III Evaluation of the Efficacy and Safety of a New Fixed-Dose Pioglitazone/Glimepiride Combination Tablet in Japanese Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 15:2, pages 158-165.
Crossref
Crossref